Combining cell types may lead to improved cardiac cell therapy following heart attack

Combining cell types may lead to improved cardiac cell therapy following heart attack
Researchers at the University of Wisconsin–Madison and other institutions have harnessed a combination of lab-grown cells to regenerate damaged heart muscle.The study, published in Circulation, addresses major challenges of using heart muscle cells…

Published January 18, 2024 at 06:00AM
Read more at nsf.gov

Comments

Popular posts from this blog

Statement on NSF Fiscal Year 2022 appropriations

Brought to you by NSF